Section I
101 – 110 of 5047
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Validation of a Digital Pathology–Based Multimodal Artificial Intelligence Biomarker in a Prospective, Real-World Prostate Cancer Cohort Treated with Prostatectomy
- Contribution to journal › Article
-
Mark
Association of Circulating Inflammatory Biomarker Levels and Toxicity in Patients Undergoing Pelvic Radiation for Cancer : A Critical Review
- Contribution to journal › Scientific review
-
Mark
Peripheral T- and natural killer-cell lymphomas : ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
- Contribution to journal › Article
-
Mark
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation : Final overall survival results from the OPINION trial
- Contribution to journal › Article
-
Mark
Twenty Years of the Paediatric Radiation Oncology Society
- Contribution to journal › Article
-
Mark
Impact of the risk-adapted Nordic anal cancer group consensus guidelines on the contouring of the elective clinical target volume in anal cancer
- Contribution to journal › Article
-
Mark
Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies
- Contribution to journal › Article
-
Mark
Gene expression-based identification of prognostic markers in lung adenocarcinoma
- Contribution to journal › Article
-
Mark
Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade Glioma
- Contribution to journal › Article
-
Mark
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
- Contribution to journal › Article
